Text & Content Analysis
This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
Explore by Category
Corpus KPIs
Entity
globaldata
Articles
2
From
2026-07-20 09:04:51+00
To
2026-07-22 14:12:20+00
Range
2026-06-22 23:06:43.445221+00 →
2026-07-22 23:06:43.445221+00
Who’s being talked about
Top Entities
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| globaldata | ORG | 2 | 📊 🔍 🧲 |
| u.s. | GPE | 2 | 📊 🔍 🧲 |
| access | PRODUCT | 1 | 📊 🔍 🧲 |
| ai | ORG | 1 | 📊 🔍 🧲 |
| bayer | ORG | 1 | 📊 🔍 🧲 |
| belgium | GPE | 1 | 📊 🔍 🧲 |
| bio campus iii | PERSON | 1 | 📊 🔍 🧲 |
| california | GPE | 1 | 📊 🔍 🧲 |
| cdmo | GPE | 1 | 📊 🔍 🧲 |
| childrens hospital colorado | WORK_OF_ART | 1 | 📊 🔍 🧲 |
| choi | ORG | 1 | 📊 🔍 🧲 |
| christoph koenen | PERSON | 1 | 📊 🔍 🧲 |
| comment samsung biologics | PERSON | 1 | 📊 🔍 🧲 |
| critical medicines act | ORG | 1 | 📊 🔍 🧲 |
| david lanfear | PERSON | 1 | 📊 🔍 🧲 |
| discover b2b marketing that performs combine | ORG | 1 | 📊 🔍 🧲 |
| dominic tyer | PERSON | 1 | 📊 🔍 🧲 |
| earlier this month | DATE | 1 | 📊 🔍 🧲 |
| ema | ORG | 1 | 📊 🔍 🧲 |
| eu | ORG | 1 | 📊 🔍 🧲 |
| europe | LOC | 1 | 📊 🔍 🧲 |
| facebook bayer | ORG | 1 | 📊 🔍 🧲 |
| fda | ORG | 1 | 📊 🔍 🧲 |
| france | GPE | 1 | 📊 🔍 🧲 |
| glp1s | PRODUCT | 1 | 📊 🔍 🧲 |
Who’s talking
Top Sources (Domains)
| Domain | Articles | % | Actions |
|---|---|---|---|
|
|
1 | 50.00 | 📊 📰 🧲 |
|
|
1 | 50.00 | 📊 📰 🧲 |
Articles included
Top entities
Top sources
Top narrative frames
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-07-22 14:12:20+00 | Business |
|
Samsung Biologics: geographic diversification is a sound business decision | Analyze | Dominic Tyer | 😐 neutral | 0.1096 |
| 2026-07-20 09:04:51+00 | Health |
|
Bayer and Henry Ford Health partner to boost clinical trial access | Analyze | Salong Debbarma | 😐 neutral | 0.1623 |